What Is a Limiting Reactant? How to Find It

Reactions almost never come with perfectly matched ingredients. One runs out, the rest sits there unused — and the one that runs out decides everything about how much product you get.

The short answer: the limiting reactant is the reactant that is completely used up first, so it sets the maximum amount of product the reaction can make. Any reactant still left over when the reaction stops is the excess reactant.

The sandwich analogy

You have 10 slices of bread and 8 slices of cheese, and each sandwich needs 2 bread + 1 cheese.

  • Bread allows 10 ÷ 2 = 5 sandwiches
  • Cheese allows 8 ÷ 1 = 8 sandwiches

You can only make 5. Bread is limiting; 3 slices of cheese are left over — the excess.

Notice you had more bread than cheese by count, and bread still ran out first. That's the whole lesson: it isn't about which you have most of, it's about how fast the recipe consumes each one. In chemistry, the "recipe" is the balanced equation's coefficients.

How to find the limiting reactant

The reliable method has three steps:

  1. Balance the equation and convert every given amount to moles (divide mass by molar mass).
  2. Divide each reactant's moles by its coefficient in the balanced equation.
  3. The smallest result is the limiting reactant.

That division is the step people skip, and it's the step that matters. Comparing raw moles — or worse, raw grams — gives the wrong answer whenever the coefficients differ.

An equivalent method: calculate how much product each reactant could make on its own, and take the smaller answer. Same logic, slightly more arithmetic.

Worked example

28.0 g of N₂ reacts with 9.00 g of H₂. Which is limiting, and how much NH₃ forms?

N₂ + 3 H₂ → 2 NH₃

Step 1 — moles.

  • N₂: molar mass 28.01 g/mol → 28.0 ÷ 28.01 = 1.00 mol
  • H₂: molar mass 2.016 g/mol → 9.00 ÷ 2.016 = 4.46 mol

At this point H₂ looks abundant — over four times as many moles. But keep going.

Step 2 — divide by the coefficients.

  • N₂: 1.00 ÷ 1 = 1.00
  • H₂: 4.46 ÷ 3 = 1.49

Step 3 — smallest wins. N₂ is the limiting reactant, despite there being fewer moles of it in the flask than of hydrogen.

Product. 1.00 mol N₂ × (2 mol NH₃ ÷ 1 mol N₂) = 2.00 mol NH₃ × 17.03 g/mol = 34.1 g NH₃.

Leftover. The reaction consumes 3 × 1.00 = 3.00 mol H₂, which is 3.00 × 2.016 = 6.05 g. So 9.00 − 6.05 = 2.95 g of H₂ is left in excess.

More worked examples

  • Water from its elements. 2 H₂ + O₂ → 2 H₂O, with 4.0 mol H₂ and 1.5 mol O₂. H₂: 4.0 ÷ 2 = 2.0. O₂: 1.5 ÷ 1 = 1.5. O₂ is limiting. Water formed = 1.5 × 2 = 3.0 mol. H₂ used = 3.0 mol, so 1.0 mol H₂ is left over.

  • Salt. 2 Na + Cl₂ → 2 NaCl, with 0.500 mol Na and 0.400 mol Cl₂. Na: 0.500 ÷ 2 = 0.250. Cl₂: 0.400 ÷ 1 = 0.400. Na is limiting, giving 0.500 mol NaCl.

  • Equal moles, different answer. N₂ + 3 H₂ → 2 NH₃ with 1.0 mol of each. N₂: 1.0 ÷ 1 = 1.0. H₂: 1.0 ÷ 3 = 0.33. H₂ is limiting — identical amounts, but hydrogen is consumed three times as fast.

Common mistakes to avoid

  • Picking whichever there's least of. In the ammonia example there was far more hydrogen by moles — 4.46 against 1.00 — and nitrogen still limited the reaction. Always divide by the coefficient.
  • Comparing grams instead of moles. Grams are meaningless here — a mole of H₂ weighs 2 g while a mole of N₂ weighs 28 g. Convert first.
  • Calculating theoretical yield from the excess reactant. Every yield calculation must start from the limiting reactant, or the prediction is too high and the percent yield comes out artificially low.

FAQ

What is a limiting reactant in simple terms?
It's the ingredient that runs out first. Once it's gone the reaction stops, so it determines the maximum amount of product that can form.

How do you find the limiting reactant?
Convert each reactant to moles, divide each by its coefficient in the balanced equation, and pick the smallest result.

What is the excess reactant?
Any reactant that isn't fully consumed. To find how much is left, subtract the amount used up from the amount you started with.

Does the limiting reactant have to be the one with the smallest mass?
No. Mass alone tells you nothing here — a reactant can be present in the largest mass and still be limiting if the equation consumes it fastest.

The takeaway

Find the limiting reactant before you calculate anything else. Moles first, divide by coefficients, smallest number wins — then that reactant, and only that reactant, sets your theoretical yield. It's two extra lines of arithmetic that keep every number after them honest.

Needed first → [What Is Stoichiometry?] and [What Is Molar Mass?] (sibling posts). Read next → [Percent Yield vs Theoretical Yield] — turning this maximum into a real-world result. Background → What Is the Mole? Avogadro's Number Made Simple.

⏰ 5 Minutes in Chemistry — the study series from Chemistery

You just learned one topic the five-minute way. The series does it for your entire course — one printable page per topic: understand it, memorize it, test yourself. Five minutes. Next topic.

  • Vol 1 · Semester 1 — atoms, moles, stoichiometry, bonding & gases (22 sheets)
  • Vol 2 · Semester 2 — kinetics, equilibrium, acids & bases, electrochem (19 sheets)
  • Vol 3 · The Hard Stuff — cram charts & decision trees for the units worth the most points (15 sheets)

Built for advanced-level high school and first-year college chem. 56 sheets, printable, Letter + A4.

$19.99 $9.99 for all three — Use code BACK2SCHOOL — back-to-school price ends Sep 15.

Get the series →

Comments

Post a Comment

Popular posts from this blog

What is Pepsin?

Image
In Your Body... Pepsin is a digestive enzyme that performed the best in the acidic condition (pH 2) produced by the gastric juice. It digests and breaks down protein (e.g. meat, seeds, eggs, dairy products, etc.). Keep in mind that pepsin digests proteins (not carbohydrates, not fat) into peptides. These peptides are then either absorbed in the intestine or further break down by enzymes from pancreas. In small intestine (pH around 7), pepsin is no longer effective and no longer digests proteins. Hormones Hormones that regulate digestion and hunger such as gastrin and secretin stimulates the production of pepsinogen, the proenzyme of pepsin. In other words, when pepsinogen is activated, it becomes pepsin.
Read more

The structure of Chimeric Antigen Receptor (CAR) III - Transmembrane Domains

Image
Transmembrane Domains Among the four components of a chimeric antigen receptor (CAR), the transmembrane domain is the least studied one. How different transmembrane domains affect and contribute to each other's functions is also not well studied. That being said, we will go through the function of a transmembrane domain of a CAR, the CD3ζ transmembrane domain, and the CD8α transmembrane domain.  Introduction of the transmembrane domain The transmembrane domain is where the transmembrane proteins are located. In a CAR, the transmembrane domain has the function to anchor the CAR to the T cell membrane. How strong the CAR is anchored to the T cell membrane affects the CAR expression level and stability.  Currently, the commonly used transmembrane domain is derived from proteins such as CD3ζ, CD4, CD8α, and CD28. The CD3ζ transmembrane domain Among the transmembrane domains mentioned, the CD3ζ transmembrane may improve CAR-mediated T cell action as the CD3ζ transmembrane medi...
Read more

Current Limitations of CAR-T Cell Therapy I - Antigen Escape

Image
Antigen Escape Antigen Escape is one of the most concerning challenges during the clinical development of CAR-T cell therapy. A robust initial response is often followed by a relapse in many trials. This is often due to the downregulation or the complete loss of target antigens on the tumor cells. Introduction Antigen escape describes the development of tumor resistance to a single antigen targeting CAR construct. After the initial encounter with the CAR-T cells, the malignant cells mutate and show partial or complete loss of the target antigen expression.  In patients with ALL treated with CD19-targeted CAR-T cell therapy, a downregulation or loss of CD19 antigens was observed.  In patients with myeloma treated with BCMA-targeted CAR-T cell therapy, a downregulation or loss of BCMA expression was observed.  In patients with glioblastoma, a solid tumor treated with IL13Ra2-targeted CAR-T cell therapy, a downregulation of IL13Ra2 expression was observed.  Improve...
Read more